Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Stevens

Showing results (21-30 of 279) with videos related to

Pageof 28
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 27, 2003
CaspofunginStanley C Deresinski, David A Stevens
Medical Mycology|June 30, 2006
Efficacy of micafungin alone or in combination against experimental pulmonary aspergillosisKarl V Clemons, David A Stevens
Antimicrobial Agents and Chemotherapy|February 26, 2004
Comparative efficacies of four amphotericin B formulations--Fungizone, amphotec (Amphocil), AmBisome, and Abelcet--against systemic murine aspergillosisKarl V Clemons, David A Stevens
Annals of the New York Academy of Sciences|March 9, 2007
Azole therapy of clinical and experimental coccidioidomycosisDavid A Stevens, Karl V Clemons
Expert Review of Anti-Infective Therapy|December 5, 2008
Third Advances Against Aspergillosis Meeting 2008David A Stevens, Karl V Clemons
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 17, 2003
Review of newer antifungal and immunomodulatory strategies for invasive aspergillosisWilliam J Steinbach, David A Stevens
Medical Mycology|November 10, 2018
Animal models of Aspergillus infection in preclinical trials, diagnostics and pharmacodynamics: What can we learn from them?Karl V Clemons, David A Stevens
Current Opinion in Infectious Diseases|June 29, 2006
Animal models testing monotherapy versus combination antifungal therapy: lessons learned and future directionsKarl V Clemons, David A Stevens
Antibiotics (Basel, Switzerland)|May 24, 2024
Antifungal Activity of Brilacidin, a Nonpeptide Host Defense MoleculeDavid J Larwood, David A Stevens
Critical Reviews in Microbiology|September 16, 2015
Caspofungin: Pharmacodynamics, pharmacokinetics, clinical uses and treatment outcomesJessica C Song, David A Stevens
Pageof 28

Showing results (21-30 of 279) with videos related to

Sort By:
Pageof 28
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 27, 2003
CaspofunginStanley C Deresinski, David A Stevens
Medical Mycology|June 30, 2006
Efficacy of micafungin alone or in combination against experimental pulmonary aspergillosisKarl V Clemons, David A Stevens
Antimicrobial Agents and Chemotherapy|February 26, 2004
Comparative efficacies of four amphotericin B formulations--Fungizone, amphotec (Amphocil), AmBisome, and Abelcet--against systemic murine aspergillosisKarl V Clemons, David A Stevens
Annals of the New York Academy of Sciences|March 9, 2007
Azole therapy of clinical and experimental coccidioidomycosisDavid A Stevens, Karl V Clemons
Expert Review of Anti-Infective Therapy|December 5, 2008
Third Advances Against Aspergillosis Meeting 2008David A Stevens, Karl V Clemons
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 17, 2003
Review of newer antifungal and immunomodulatory strategies for invasive aspergillosisWilliam J Steinbach, David A Stevens
Medical Mycology|November 10, 2018
Animal models of Aspergillus infection in preclinical trials, diagnostics and pharmacodynamics: What can we learn from them?Karl V Clemons, David A Stevens
Current Opinion in Infectious Diseases|June 29, 2006
Animal models testing monotherapy versus combination antifungal therapy: lessons learned and future directionsKarl V Clemons, David A Stevens
Antibiotics (Basel, Switzerland)|May 24, 2024
Antifungal Activity of Brilacidin, a Nonpeptide Host Defense MoleculeDavid J Larwood, David A Stevens
Critical Reviews in Microbiology|September 16, 2015
Caspofungin: Pharmacodynamics, pharmacokinetics, clinical uses and treatment outcomesJessica C Song, David A Stevens
Pageof 28